📊 Get daily AI-graded market briefings
Morning + evening · AI impact + sector exposure · Free
LAST 30 DAYS
4 articles
AVG GRADE
HIGH
score: 0.62
SENTIMENT
BULLISH
TOTAL VIEWS
16
NEO Stock Analysis & AI Grade: HIGH
4 articles analyzed · Sentiment: BULLISH · AI-powered equity research
RECENT COVERAGE · 4 ARTICLES
Leaving Estimates in the Dust: 28 Firms Beating Earnings Expectations
The broader S&P 500 achieved a 6% median EPS surprise in Q1 2026, marking the strongest earnings beat cycle in four years and...
NeoGenomics anticipates $802M-$806M 2026 revenue as it targets mid-20% NGS growth and adjusts pharma expectations (NASDAQ:NEO)
NeoGenomics (NEO) raised full-year 2026 revenue guidance to $802M–$806M, signaling confidence in underlying demand drivers across its...
NeoGenomics, Inc. (NEO) Q2 2026 Earnings Call Transcript
NeoGenomics (NEO) released Q2 2026 earnings results via transcript, providing institutional investors with detailed operational and...
Freenome Debuts as a Publicly Traded Company Focused on Blood-Based Early Cancer Detection
Freenome's public market debut marks a significant milestone in the liquid biopsy sector, introducing blood-based early cancer detection...
RELATED TICKERS
E
ESEN Analytics
AI-powered equity research platform covering 5,000+ US equities. Our proprietary AI grading system (A+ to D scale) analyzes fundamentals, technicals, and news sentiment daily. Coverage data updated every 24 hours.
Learn about our methodology →
ⓘ AI-graded news coverage · Not investment advice